HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Savino Bruno Selected Research
Savino Bruno Research Topics
Disease
24
Fibrosis (Cirrhosis)
03/2019 - 01/2006
14
Infections
03/2019 - 09/2004
13
Chronic Hepatitis C
03/2019 - 04/2003
11
Hepatocellular Carcinoma (Hepatoma)
01/2019 - 05/2009
7
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 03/2010
5
Hepatitis C
03/2019 - 02/2010
4
Liver Neoplasms (Liver Cancer)
01/2018 - 02/2016
4
Crohn Disease (Crohn's Disease)
12/2015 - 02/2012
4
Ulcerative Colitis
12/2015 - 02/2012
3
End Stage Liver Disease
01/2018 - 10/2015
3
Hemorrhage
03/2010 - 10/2006
3
Chronic Hepatitis (Chronic Active Hepatitis)
01/2008 - 09/2004
2
Liver Diseases (Liver Disease)
09/2017 - 08/2016
2
Disease Progression
12/2016 - 08/2016
2
Neoplasms (Cancer)
05/2016 - 03/2011
2
Virus Diseases (Viral Diseases)
01/2015 - 01/2011
2
Ascites
12/2011 - 05/2009
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2008 - 12/2006
1
Hypertension (High Blood Pressure)
10/2018
1
Necrosis
01/2018
1
Spontaneous Abortion (Miscarriage)
09/2017
1
Hepatitis
09/2017
1
Varicose Veins (Varicose Vein)
12/2016
1
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2016
1
Portal Hypertension
05/2016
1
Thrombocytopenia (Thrombopenia)
10/2015
1
Dysgeusia (Parageusia)
05/2014
1
Thrombosis (Thrombus)
09/2013
1
Venous Thrombosis (Deep-Vein Thrombosis)
09/2013
1
Acquired Immunodeficiency Syndrome (AIDS)
03/2013
1
Drug-Related Side Effects and Adverse Reactions
08/2012
1
Skin Ulcer
06/2011
1
Peripheral Nervous System Diseases (PNS Diseases)
06/2011
1
Glomerulonephritis
06/2011
1
Vasculitis (Vasculitides)
06/2011
1
Anemia
03/2011
1
Persistent Infection
03/2011
1
Inflammation (Inflammations)
01/2011
1
Thrombophilia
03/2010
1
Chronic Hepatitis B
09/2009
1
Hepatic Encephalopathy
05/2009
1
Staphylococcal Infections
05/2009
1
Salmonella Infections (Salmonellosis)
05/2009
1
Lymphoma (Lymphomas)
10/2008
Drug/Important Bio-Agent (IBA)
17
Antiviral Agents (Antivirals)
IBA
03/2019 - 01/2006
16
Ribavirin (Virazole)
FDA Link
Generic
03/2019 - 09/2004
13
Interferons
IBA
03/2019 - 04/2003
5
Ritonavir (Norvir)
FDA Link
03/2019 - 12/2014
5
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
10/2014 - 03/2011
4
ombitasvir
IBA
03/2019 - 12/2014
4
paritaprevir
IBA
03/2019 - 12/2014
4
RNA (Ribonucleic Acid)
IBA
11/2017 - 02/2010
3
dasabuvir
IBA
10/2018 - 12/2014
3
Albumins
IBA
10/2018 - 12/2011
3
Antibodies
IBA
01/2018 - 09/2013
2
grazoprevir
IBA
11/2017 - 08/2014
2
peginterferon alfa-2b (Pegintron)
FDA Link
05/2014 - 09/2004
2
Immunoglobulin M (IgM)
IBA
03/2013 - 07/2012
1
Sofosbuvir
IBA
03/2019
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2018
1
Angiopoietin-2
IBA
01/2018
1
uprifosbuvir
IBA
11/2017
1
ruzasvir
IBA
11/2017
1
Long-Acting Thyroid Stimulator (LATS)
IBA
05/2016
1
Interleukin-6 (Interleukin 6)
IBA
12/2015
1
Interleukin-9 (Interleukin 9)
IBA
12/2015
1
Interleukin-13
IBA
12/2015
1
Interleukin-4 (Interleukin 4)
IBA
12/2015
1
Interleukin-5 (Interleukin 5)
IBA
12/2015
1
Immunosorbents
IBA
12/2015
1
Enzymes
IBA
12/2015
1
eltrombopag
FDA Link
10/2015
1
danoprevir
IBA
01/2015
1
Protease Inhibitors (Protease Inhibitor)
IBA
05/2014
1
Prothrombin (Factor II)
IBA
09/2013
1
APT
IBA
09/2013
1
telaprevir
IBA
06/2013
1
Methotrexate (Mexate)
FDA Link
Generic
02/2012
1
Vasoconstrictor Agents
IBA
12/2011
1
Rituximab (Mabthera)
FDA Link
06/2011
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2011
1
Thrombomodulin
IBA
03/2010
1
Thrombin
FDA Link
03/2010
1
peginterferon alfa-2a (Pegasys)
FDA Link
02/2010
1
NK Cell Lectin-Like Receptor Subfamily K
IBA
09/2009
1
Natural Killer Cell Receptors
IBA
09/2009
1
Interferon-gamma (Interferon, gamma)
IBA
09/2009
1
Cytokines
IBA
09/2009
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2009
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
08/2008
1
Interferon-alpha2b
IBA
01/2008
Therapy/Procedure
22
Therapeutics
01/2018 - 04/2003
2
Liver Transplantation
05/2016 - 05/2009
2
Radiofrequency Ablation
05/2016 - 02/2016
1
Duration of Therapy
03/2019
1
Precision Medicine
08/2016
1
Drug Tapering
03/2011
1
Length of Stay
05/2009
1
Drug Therapy (Chemotherapy)
10/2008